X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-01 | SLRN | Lin Shao-Lee | CEO | S - Sale | $6.63 | -9,961 | 3,452,329 | 0% | -$66,024 | ||||||
2024-02-20 | SLRN | Lin Shao-Lee | CEO | S - Sale | $7.60 | -15,701 | 3,462,290 | 0% | -$119,403 | ||||||
2024-01-02 | SLRN | Lin Shao-Lee | CEO | S - Sale | $7.41 | -10,691 | 3,477,991 | 0% | -$79,188 | ||||||
| D | 2023-05-09 | SLRN | Westlake Biopartners Fund Ii, L.P. | 10% | P - Purchase | $18.00 | +1,250,000 | 9,790,729 | +15% | +$22,500,000 | |||||
| D | 2023-05-09 | SLRN | Seidenberg Beth C | Dir, 10% | P - Purchase | $18.00 | +1,310,000 | 9,850,729 | +15% | +$23,580,000 | |||||
| D | 2023-05-09 | SLRN | Svoronos Dawn | Dir | P - Purchase | $18.00 | +15,000 | 15,000 | New | +$270,000 | |||||
| D | 2023-05-09 | SLRN | Gosebruch Henry O | Dir | P - Purchase | $18.00 | +50,000 | 50,000 | New | +$900,000 | |||||
| D | 2023-05-09 | SLRN | Becker Daniel J. | Dir | P - Purchase | $18.00 | +3,000 | 3,000 | New | +$54,000 | |||||
| D | 2023-05-09 | SLRN | Oyston Ronald | Chief People Officer | P - Purchase | $18.00 | +1,026 | 1,026 | New | +$18,468 | |||||
| D | 2023-05-09 | SLRN | Kim Mina | Chief Legal, Admin. Officer | P - Purchase | $18.00 | +5,000 | 5,000 | New | +$90,000 | |||||
| D | 2023-05-09 | SLRN | Peloso Paul | Chief Medical Officer | P - Purchase | $18.00 | +6,000 | 6,000 | New | +$108,000 | |||||
| D | 2023-05-09 | SLRN | Dier Mardi | CFO, CBO | P - Purchase | $18.00 | +7,306 | 6,431 | -835% | +$131,508 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |